16
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The additive and/or synergistic effects of combined sympathomimetic and methylxanthine therapy

Pages 85-91 | Accepted 14 May 1979, Published online: 21 Aug 2008
 

Summary

Synergism between sympathomimetics and methylxanthines has been demonstrated in vitro. A series of 4 studies was carried out to investigate the synergistic effects of the two classes of drugs in vivo. The effects over α 2-hour period of inhaled isoprenaline and intravenous aminophylline were studied in 38 asthmatic patients. The results showed that when both drugs were given together there was a definite additive effect on the maximum expiratory flow and on the maximum mid-expiratory flow with a strong suggestion of synergism on the latter. Combining choline theophyllinate andsalmefamol, both given orally, resulted in an additive effect on peak expiratory flow rate in another group of 54 asthmatic patients but a synergistic effect on tremor of the hands. A further study in 14 patients receiving oral theophylline and inhaled salbutamol failed to demonstrate any additive effect when the two drugs were given together, and the results, so far, of an on-going study inpatients recovering from status asthmaticus have shown no interaction between inhaled rimiterol and oral theophylline. The clinical significance of the results is discussed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.